Cargando…
Prospective, double-blind, placebo-controlled randomized trial of cimetidine in gastric cancer
Cimetidine is thought to inhibit suppressor T-lymphocyte function and preliminary evidence from a randomized trial indicated that it might prolong survival for patients with operable and inoperable gastric cancer. The British Stomach Cancer Group conducted a randomized, double-blind, placebo-control...
Autores principales: | Langman, M J S, Dunn, J A, Whiting, J L, Burton, A, Hallissey, M T, Fielding, J W L, Kerr, D J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362962/ https://www.ncbi.nlm.nih.gov/pubmed/10604733 http://dx.doi.org/10.1038/sj.bjc.6690457 |
Ejemplares similares
-
Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer
por: Maxwell-Armstrong, C A, et al.
Publicado: (2001) -
Histamine, mast cells and tumour cell proliferation in breast cancer: does preoperative cimetidine administration have an effect?
por: Bowrey, P F, et al.
Publicado: (2000) -
Cimetidine in the Treatment of Herpes Zoster
por: Levy, D. W., et al.
Publicado: (1985) -
Cimetidine and therapy of rodent tumours.
por: Hannant, D., et al.
Publicado: (1982) -
Effectiveness of Cimetidine as Adjuvant Therapy in the Treatment of Acute-Extrinsic Atopic Dermatitis: A Double-Blind Randomized Controlled Trial
por: Novianto, Endi, et al.
Publicado: (2022)